/

/

RNA-Targeted Therapeutics

RNA-Targeted Therapeutics

Showing all 3 resultsSorted by latest

November of 2022

RNA-Targeted Novel Drug Modalities Based on RNA Editing, Epitranscriptomics, Direct RNA Targeting, Splicing Modulation, Translation Regulation, lncRNA & regRNA Targeting & More: a landscape analysis of technologies, targets, business and financing from an industry perspective

This report provides a landscape description and analysis of discovery and development of novel drug modalities targeting RNA from an industry perspective as of November 2019.

€ 2350.00
May of 2020

Report Package: “Drug the Undruggable” Technologies

This report package includes four reports for the price of two describing and analyzing the landscape of novel technologies to drug the undruggable targets from an industry perspective.

Original price was: € 8250.00.Current price is: € 4125.00.
September of 2019

RNA-Targeted Small Molecules 2019: a landscape analysis of companies, technologies, targets, investors and partners from an industry perspective

This report provides a landscape description & analysis of discovery & development of small molecules against RNA as a drug target from an industry perspective

€ 2050.00